Hims & Hers Health, Inc. has announced that its Board of Directors authorized a share repurchase program of up to $250 million of outstanding Class A common stock over the next three years. This authorization follows the completion of the company's prior $100 million share repurchase program, which has now been fully utilized. The program allows the company to repurchase shares at its discretion through various methods, including open market purchases and privately negotiated transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251117198095) on November 17, 2025, and is solely responsible for the information contained therein.